BACKGROUND AND PURPOSE: The technology of catheter- based aortic valve implantation is a new, less invasive therapeutic option for patients with symptomatic high-grade aortic stenosis. The present paper aims to demonstrate that optimal therapy should be provided by a multidisciplinary team consisting of cardiac surgeons, cardiologists and cardioanesthesiologists in a hybrid suite. PATIENTS AND METHODS: From June 2007 to April 2009, 234 patients have been treated by transcatheter aortic valve implantation through different access sites (n = 168 femoral artery, n = 56 left ventricular apex, n = 7 subclavian artery, n = 3 ascending aorta) at the German Heart Center Munich, Germany. An algorithm for the choice of the most appropriate access site for the individual patient was established. RESULTS: The 30-day mortality was 11.2% in this high-risk patient cohort. A certain number of periprocedural complications required surgical management. There was a considerable clinical improvement of the patients 6 months after the procedure. CONCLUSION: Integrating the new methods of aortic valve implantation into a cardiac surgery program, all kinds of surgical and interventional treatment options may be offered to the patient with aortic stenosis by one multidisciplinary team. A qualified and safe performance of transcatheter aortic valve implantation and the management of potential complications require the presence of a hybrid suite.
BACKGROUND AND PURPOSE: The technology of catheter- based aortic valve implantation is a new, less invasive therapeutic option for patients with symptomatic high-grade aortic stenosis. The present paper aims to demonstrate that optimal therapy should be provided by a multidisciplinary team consisting of cardiac surgeons, cardiologists and cardioanesthesiologists in a hybrid suite. PATIENTS AND METHODS: From June 2007 to April 2009, 234 patients have been treated by transcatheter aortic valve implantation through different access sites (n = 168 femoral artery, n = 56 left ventricular apex, n = 7 subclavian artery, n = 3 ascending aorta) at the German Heart Center Munich, Germany. An algorithm for the choice of the most appropriate access site for the individual patient was established. RESULTS: The 30-day mortality was 11.2% in this high-risk patient cohort. A certain number of periprocedural complications required surgical management. There was a considerable clinical improvement of the patients 6 months after the procedure. CONCLUSION: Integrating the new methods of aortic valve implantation into a cardiac surgery program, all kinds of surgical and interventional treatment options may be offered to the patient with aortic stenosis by one multidisciplinary team. A qualified and safe performance of transcatheter aortic valve implantation and the management of potential complications require the presence of a hybrid suite.
Authors: Thomas Walther; Volkmar Falk; Jörg Kempfert; Michael A Borger; Jens Fassl; Michael W A Chu; Gerhard Schuler; Friedrich W Mohr Journal: Eur J Cardiothorac Surg Date: 2008-02-21 Impact factor: 4.191
Authors: Alec Vahanian; Ottavio Alfieri; Nawwar Al-Attar; Manuel Antunes; Jeroen Bax; Bertrand Cormier; Alain Cribier; Peter De Jaegere; Gerard Fournial; Arie Pieter Kappetein; Jan Kovac; Susanne Ludgate; Francesco Maisano; Neil Moat; Friedrich Mohr; Patrick Nataf; Luc Piérard; José Luis Pomar; Joachim Schofer; Pilar Tornos; Murat Tuzcu; Ben van Hout; Ludwig K Von Segesser; Thomas Walther Journal: Eur Heart J Date: 2008-05-12 Impact factor: 29.983
Authors: Thomas Walther; Paul Simon; Todd Dewey; Gerhard Wimmer-Greinecker; Volkmar Falk; Marie T Kasimir; Mirko Doss; Michael A Borger; Gerhard Schuler; Dietmar Glogar; Wolfgang Fehske; Ernst Wolner; Friedrich W Mohr; Michael Mack Journal: Circulation Date: 2007-09-11 Impact factor: 29.690
Authors: Lars G Svensson; Todd Dewey; Samir Kapadia; Eric E Roselli; Alan Stewart; Matt Williams; William N Anderson; David Brown; Marty Leon; Bruce Lytle; Jeffrey Moses; Michael Mack; Murat Tuzcu; Craig Smith Journal: Ann Thorac Surg Date: 2008-07 Impact factor: 4.330
Authors: Jian Ye; Anson Cheung; Samuel V Lichtenstein; Lukas A Altwegg; Daniel R Wong; Ronald G Carere; Christopher R Thompson; Robert R Moss; Brad Munt; Sanjeevan Pasupati; Robert H Boone; Jean-Bernard Masson; Abdullah Al Ali; John G Webb Journal: J Thorac Cardiovasc Surg Date: 2008-10-23 Impact factor: 5.209